Cronos Group Inc. to Speak at Stifel Canada’s 3rd Annual Future of Healthcare Conference

Cannabis12 karnauhov 1 Cronos Group Inc. to Speak at Stifel Canada's 3rd Annual Future of Healthcare Conference

TORONTO, Nov. 29, 2022 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and Chief Executive Officer, will speak at Stifel Canada’s 3

rd

Annual Future of Healthcare Conference on Wednesday, December 7, 2022 at 1:00 p.m. ET.

A webcast will be available on the Investors section of the Company’s website at:

https://ir.thecronosgroup.com/events-presentations

.


About Cronos


Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes Spinach

®

, PEACE NATURALS

®

, Lord Jones

®

, Happy Dance

®

and PEACE+

®

. For more information about Cronos and its brands, please visit:

thecronosgroup.com

.


Forward-looking Statements


This press release may contain information that may constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws and court decisions (collectively, “Forward-looking Statements”). All information contained herein that is not clearly historical in nature may constitute Forward-looking Statements. In some cases, Forward-looking Statements can be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “plan”, “anticipate”, “intend”, “potential”, “estimate”, “believe” or the negative of these terms, or other similar expressions intended to identify Forward-looking Statements. Some of the Forward-looking Statements contained in this press release include the Company’s intention to build an international iconic brand portfolio and develop disruptive intellectual property. Forward-looking Statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, financial results, results, performance or achievements expressed or implied by those Forward-looking Statements and the Forward-looking Statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, Quarterly Report on Form 10-Q for the period ended March 31, 2022, Quarterly Report on Form 10-Q for the period ended June 30, 2022, and Quarterly Report on Form 10-Q for the period ended September 30, 2022, all of which have been filed on SEDAR and EDGAR and can be accessed at www.sedar.com and www.sec.gov/edgar, respectively. Any Forward-looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos disclaims any obligation to update or revise any Forward-looking Statement. Readers are cautioned not to put undue reliance on any Forward-looking Statement.


Cronos Group Contact


Shayne Laidlaw

Investor Relations

Tel: (416) 504-0004


[email protected]

ti?nf=ODcwNTUyOCM1Mjg4NDkzIzIwOTYzMzk= Cronos Group Inc. to Speak at Stifel Canada's 3rd Annual Future of Healthcare Conference


Primary Logo

Featured image: DepositPhotos © karnauhov

Disclaimer